Pharmaceutical
ChemLinkedMarketChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
OUR SERVICE
In all critical stages in the drug life cycle, BaiPharm can provide specific recommendations and actionable solutions to clients.

Product Registration
Pharmacovigilance
Local Agency Support
Consulting and Training
WEBINARS MORE >
webinar cover Investigational New Drug (IND) Preparation for U.S. FDA Submission
[ Thursday, 26th September 2024 ]
webinar cover A Look Back at 2023: Pharmaceutical Regulatory Updates in China
[ Tuesday, 30th January 2024 ]
webinar cover Understanding Regulatory Requirements for Exporting Drugs to Cambodia, Laos, and Myanmar
[ Wednesday, 13th December 2023 ]
webinar cover Understanding Regulatory Requirements for Exporting Drugs to Indonesia and Vietnam
[ Thursday, 30th November 2023 ]
LATEST NEWS
INDUSTRY
Innovative Drug Rare Disease China
Current Landscape of Oligonucleotide Drugs in China Compared to the global market, China currently lags in the development of oligonucleotide drugs.
Oct 09, 2024
INDUSTRY
Innovative Drug Biological Product Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | August 2024 In August 2024, China NMPA approved 17 new drugs, among which 7 are chemical drugs and 10 are biological products.
Sep 15, 2024
REGULATION
Law & Regulation Marketing Approval NRDL OTC Drug China
Monthly Recap: China Pharmaceutical Regulatory Updates | August 2024 Check out the latest pharma regulatory updates in China: 1. China CDE Solicits Public Comments on the 85th RLD Lists, 2. China NHSA Announces 440 Drugs Having Passed the Format Review for NRDL, 3. China NMPA Grants Five Rx-to-OTC Switches, 4. China Consults on the Overarching Regulation of Medical Devices, 5. China CDE Releases the 82nd RLD List...
Sep 12, 2024
REGULATION
Law & Regulation Pediatric Drug China
China Releases The Fifth List of Pediatric Drugs Encouraged for R&D On September 9, China's National Health Commission (NHC), Ministry of Industry and Information Technology (MIIT), National Healthcare Security Administration (NHSA), and National Medical Products Administration (NMPA) jointly announced the Fifth List of Pediatric Drugs Encouraged for R&D and Marketing Authorization, containing 15 drugs in total.
Sep 11, 2024
REGULATION
Law & Regulation Medical Device China
China Consults on the Overarching Regulation of Medical Devices On August 28, 2024, China’s National Medical Products Administration (NMPA) released the Draft for Comments on the Medical Device Administration Law for public consultation. The draft places particular emphasis on fostering innovation and enhancing regulatory oversight throughout the entire lifecycle of medical devices.
Aug 30, 2024
INDUSTRY
Priority Review Innovative Drug Generic Drug Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | July 2024 In July 2024, China NMPA approved 20 new drugs, among which 15 are chemical drugs and 5 are biological products.
Aug 13, 2024
REGULATION
Law & Regulation Clinical Trial Innovative Drug Drug Registration New Drug China
China NMPA Launches Pilot Program to Speed Up Approval for Innovative Drug Clinical Trials On July 31, 2024, China's NMPA launched a pilot program aimed at improving the review and approval process for innovative drug clinical trials.
Aug 09, 2024
REGULATION
Law & Regulation GMP Innovative Drug OTC Drug Drug Registration Packaging Excipient China
Monthly Recap: China Pharmaceutical Regulatory Updates | July 2024 Check out the latest pharma regulatory updates in China: 1. China CDE Accepts Online Submission of Electronic Drug Registration Documents; 2. China Customs Consults on the Importation of Bezoar; 3. China NMPA Grants Three Rx-to-OTC Switches; 4. China NMPA Consults on Good Manufacturing Practices for Excipients and Packaging Materials; 5. China NMPA Launches Pilot Program to Speed Up Approval for Innovative Drug Clinical Trials
Aug 07, 2024
MORE >
INSIGHTS MORE >
cover Decoding China's Good Pharmacovigilance Practices (GVP)
cover 2023 China CDE Drug Evaluation Report
cover China's Drug Supply Regulations Come into Effect
adv-image adv-image adv-image